Return to Trial Database

BTCRC-GI13-002

An Open Label Randomized Phase I/II Trial of MLN0128 Compared to Sorafenib in Patients With Advanced or Metastatic Hepatocellular Carcinoma: Big Ten Cancer Research Consortium BTCRC-GI13-002

Status

Study Completed

Cancer Type(s)

Liver and Bile Duct

Study Contact

Trial Locations

All sites in which the trial BTCRC-GI13-002 being conducted in.

No data was found